News Category
Viromed Medical AG signs distribution agreements for its cold plasma device ViroCAP® in six new markets, expecting at least 3,000 additional device sa...
Quantum BioPharma's FDA approval to proceed with Phase 2 trials for its novel multiple sclerosis drug, Lucid-MS, marks a significant step toward a the...
PX1 Research introduces a line of US-manufactured sublingual peptide strips, including Retatrutide, Tirzepatide, and BPC-157, offering a needle-free a...
PX1 Research's expansion of cGMP quality control and HPLC purity verification to all US-manufactured research peptides ensures 99%+ purity and batch-s...
NanoViricides has received regulatory approval from the DRC to begin a Phase II trial of its oral antiviral NV-387 for Ebola, potentially offering a m...
University of Virginia research suggests focused ultrasound could enhance drug delivery to deadly brain tumors, offering a less harmful targeted treat...
Telomir Pharmaceuticals announced peer-reviewed preclinical data showing Telomir-Zn suppresses tumor growth in triple-negative breast cancer models, p...
Park-Ohio's second-quarter results show a clear inflection in its core portfolio, with improved margins and raised guidance, suggesting a multi-step i...
ICON Smile Studios opens two flagship campuses in Virginia Beach and Norfolk, uniting orthodontics, periodontics, pediatric dentistry, and oral surger...
Scinai Immunotherapeutics strengthens its CDMO operations with the appointment of Eran Kuratz as head of supply chain and business process administrat...
Quantum BioPharma's FDA clearance to advance Lucid-MS into Phase 2 marks a pivotal step toward a potential neuroprotective therapy for multiple sclero...
Tonix Pharmaceuticals' second-quarter revenue soared to $13.5 million, driven by strong TONMYA sales, signaling a promising market entry for the first...
Tonix Pharmaceuticals' second-quarter revenue surged to $13.5 million, driven by TONMYA sales of $11 million, marking a significant commercial milesto...
Tonix Pharmaceuticals' second-quarter 2026 revenue surged to $13.5 million, led by TONMYA sales, while the company advances key clinical trials, under...
Voyageur Pharmaceuticals announced successful laboratory results of 99.8% pure iodine recovery from oilfield brine, with field pilot testing planned, ...
OffScript's new sublingual nootropic mints offer fully disclosed dosing, third-party testing, and a portable format, addressing consumer demand for cl...
A new narrative review provides a comprehensive framework for risk-adapted treatment of neuroblastoma, emphasizing the importance of molecular and cli...
Regentis Biomaterials is progressing its GelrinC cartilage regeneration technology through U.S. clinical trials, FDA submission preparation, European ...
Quantum BioPharma's two-pronged approach, including its investigational MS therapy Lucid-MS and the unbuzzd supplement, highlights a strategic shift t...
Quantum BioPharma is advancing a two-pronged approach to neurological health with its MS therapy Lucid-MS and alcohol metabolism supplement unbuzzd, a...
VERAXA Biotech's proprietary BiTAC platform and pipeline of bispecific ADCs and T-cell engagers position it for potential partnerships and licensing d...
A Spanish patient's brain cancer misdiagnosis, caused by pork tapeworm cysts, underscores the dangers of undercooked pork and the need for better diag...
Veetee USA appoints Kevin Stitt to spearhead retail growth at Walmart and Publix, leveraging its unique steam-cooked rice and domestic manufacturing t...
Lantern Pharma's upcoming webcast to discuss Q2 2026 results underscores its strategic focus on AI-driven drug development and commercialization of it...
Earth Science Tech's fiscal Q1 2027 results show a 57% year-over-year net income increase to $715,697, reflecting strong operational performance and s...
Thorium Atomics has initiated pre-application regulatory engagement with the U.S. Nuclear Regulatory Commission, marking a key step in the licensing p...
VERAXA Biotech's VXA-222 bispecific antibody-drug conjugate program has progressed past discovery, and the company has expanded its intellectual prope...
American Fusion Inc. files six additional U.S. patent applications, bringing its total to 82, and progresses toward OTCQB listing and next-phase testi...
Nano-X Imaging announced an $8 million registered direct offering with a single institutional investor, signaling continued capital infusion to advanc...
A new liquid biopsy offers a simpler way to forecast which advanced lung cancer patients will benefit from immunotherapy, potentially improving treatm...
GeoVax announced completion of manufacturing, regulatory, clinical, and preclinical milestones for its GEO-MVA mpox/smallpox vaccine, positioning it f...
Innovative Designs, Inc. announces its best quarter in company history, with a near 40% increase in sales revenue and its eighth consecutive profitabl...
The July Wellness Index Report reveals a growing trend in longevity medicine that focuses on enhancing natural biological processes rather than overri...
Regentis Biomaterials' GelrinC, a cell-free hydrogel implant, gains European approval for a new manufacturing process that boosts yield by 400%, posit...
Purple Exhibits announces Joey Bartman's oversight for all KBIS 2027 projects, ensuring expert guidance and quality control for exhibitors.
Onco-Innovations is advancing a multi-pronged approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI to develop cancer treatme...
Earth Science Tech's strategic focus on technology and vertical integration positions it to capitalize on the growing telehealth and peptide therapy m...
Episode 812 of DH Unplugged dissects a volatile week of Big Tech earnings, a Korean stock market crash, and SpaceX's post-IPO slump, highlighting inve...
Nagoya University researchers discovered that the C3 protein, naturally produced in the body, can make tumors more susceptible to immunotherapy, poten...
American Fusion Inc. presented its Texatron Fusion Engine development and related GEM Unification Theory at the APS DPF 2026 meeting, potentially boos...
VolitionRx's new Capture-Seq technology, detailed in a peer-reviewed study, achieves over 99% pure ctDNA, potentially transforming multi-cancer early ...
Tonix Pharmaceuticals announced its participation in two major investor conferences, highlighting its commitment to engaging with the investment commu...
VERAXA Biotech has advanced its VXA-222 bispecific antibody-drug conjugate into the next development stage and expanded its patent portfolio, strength...
LataMed AI will discuss AI's role in healthcare and systems engineering at a university conference in Caracas, emphasizing professional oversight and ...
NeuroThera Labs has initiated its Phase IIb clinical trial for SCI-110, a novel cannabinoid-based treatment for Tourette syndrome, at the Yale Child S...
Medios AG has appointed Katrin Neuffer as Director Investor Relations & Communications, succeeding Claudia Nickolaus, to strengthen its capital market...
SRX Global's strategic investment in Vistagen Therapeutics underscores its commitment to unlocking shareholder value in undervalued biopharmaceutical ...
SRX Global's acquisition of a stake in Vistagen Therapeutics underscores its strategy of investing in undervalued high-conviction companies, potential...
